Scientific publications and books linked to TransBioLine:
- Magnitude of Urine Albumin and KIM-1 Changes Can be Used to Differentiate Glomerular Injury From Tubular Injury in Rats
- Study design for development of novel safety biomarkers of drug induced liver injury by the translational safety biomarker pipeline (TransBioLine) consortium: a study protocol for a nested case–control study
- Update on herbal and dietary supplement-induced liver injury: current gaps and future directions.
- Incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury: A 10-year real-world retrospective cohort study
- Performance of biomarkers NF-L, NSE, Tau and GFAP in blood ans cerebrospinal fluid in rat for the detection of nervous system injury
- Relapse and need for extended immunosuppression: Novel Features of drug-induced autoimmune hepatitis
- Acute pancreatitis: diagnosis and treatment
- Plasma sphingoid base profiles of patients diagnosed with intrinsic or idiosyncratic drug-induced liver injury
- Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated
- Systems analysis of miRNA biomarkers to inform drug safety
- Zanubrutinib-induced liver injury: a case report and literature review
- Evaluating the Sensitivity and Specificity of Promising Circulating Biomarkers to Diagnose Liver Injury in Humans
- Drug-induced liver injury (DILI): Current status and future directions for drug development and the post-market setting. A consensus by a CIOMS Working Group
- Incidence and prevalence of acute hepatitis E virus infection in patients with suspected Drug-induced Liver Injury in the Spanish DILI Registry
- The Sodium Channel B4-Subunits are Dysregulated in Temporal Lobe Epilepsy Drug-Resistant Patients
- Protective Effects of Necrostatin-1 in Acute Pancreatitis: Partial Involvement of Receptor Interacting Protein Kinase 1
- Biomarkers of idiosyncratic drug-induced liver injury (DILI) – a systematic review
- Neurofilament proteins as translational biomarker for the development of chemotherapy-induced neuropathy
- Association of cardiometabolic microRNAs with COVID-19 severity and mortality
- MicroRNA Next-Generation-Sequencing Discovery Assay (miND) for Genome-Scale Analysis and Absolute Quantitation of Circulating MicroRNA Biomarkers
- Drug-induced Liver Injury (DILI): A Major Challenge
- miND (miRNA NGS Discovery pipeline): a small RNA-seq analysis pipeline and report generator for microRNA biomarker discovery studies
- Genomics and transcriptomics landscapes associated to changes insulin sensitivity in response to exercise
- Challenges and Future of Drug-Induced Liver Injury Research – Laboratory Tests
- A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry.
- Plasma Biomarkers TAP, CPA1, and CPA2 for the Detection of Pancreatic Injury in Rat: The development of a Novel Multiplex IA-LC-MS/MS Assay and Biomarker Performance Evaluation
- Biomarkers of idiosyncratic drug-induced liver injury (DILI) – a systematic review